You just read:

Bernstein Liebhard LLP Launches Uloric Lawsuit Investigation, After FDA Concludes Febuxostat Increases Risk for Heart-Related Death and Death from All Causes Compared to Alternative Gout Medication

News provided by

Bernstein Liebhard LLP

Mar 07, 2019, 13:11 ET